theory clinical_105_3
imports Main

begin

typedecl entity
typedecl event

consts
  Trastuzumab :: "entity ⇒ bool"
  HER2 :: "entity ⇒ bool"
  ExtracellularDomain :: "entity ⇒ bool"
  Bind :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Specifically :: "event ⇒ bool"
  Mutation :: "entity ⇒ bool"
  IntracellularDomain :: "entity ⇒ bool"
  Inhibit :: "event ⇒ bool"
  HER2V777L :: "entity ⇒ bool"
  IntracellularTyrosineKinaseDomain :: "entity ⇒ bool"
  LocatedIn :: "entity ⇒ entity ⇒ bool"
  Resistance :: "entity ⇒ bool"
  AntibodyTherapy :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  To :: "entity ⇒ entity ⇒ bool"
  Location :: "entity ⇒ entity ⇒ bool"
  Target :: "event ⇒ bool"
  By :: "event ⇒ entity ⇒ bool"
  Lead :: "event ⇒ bool"

(* Explanation 1: Trastuzumab binds specifically to the HER2 extracellular domain, and this binding does not inhibit mutations located in the intracellular kinase domain. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. Trastuzumab x ∧ HER2 y ∧ ExtracellularDomain y ∧ Bind e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Specifically e1 ∧ Mutation z ∧ IntracellularDomain z ∧ Inhibit e2 ∧ ¬Agent e2 x ∧ Patient e2 z"

(* Explanation 2: The HER2 V777L mutation is located in the intracellular tyrosine kinase domain. *)
axiomatization where
  explanation_2: "∃x y. HER2V777L x ∧ Mutation x ∧ IntracellularTyrosineKinaseDomain y ∧ LocatedIn x y"

(* Explanation 3: HER2 V777L may cause resistance to antibody therapy due to its location in the intracellular domain, which is not targeted by trastuzumab. *)
axiomatization where
  explanation_3: "∃x y z w e1 e2. HER2V777L x ∧ Resistance y ∧ AntibodyTherapy z ∧ IntracellularDomain w ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ To y z ∧ Location x w ∧ Target e2 ∧ ¬Agent e2 w ∧ Patient e2 x ∧ By e2 y"

(* Explanation 4: The location of the HER2 V777L mutation in the intracellular tyrosine kinase domain can lead to resistance to trastuzumab, as trastuzumab targets the extracellular domain. *)
axiomatization where
  explanation_4: "∃x y z w e1 e2. HER2V777L x ∧ Mutation x ∧ IntracellularTyrosineKinaseDomain y ∧ Resistance z ∧ Trastuzumab w ∧ Location x y ∧ Lead e1 ∧ Agent e1 y ∧ Patient e1 z ∧ To z w ∧ Target e2 ∧ Agent e2 w ∧ Patient e2 y"

theorem hypothesis:
  assumes asm: "HER2V777L x ∧ Trastuzumab y ∧ Resistance z"
  (* Hypothesis: HER2 V777L may cause resistance to trastuzumab, as trastuzumab binds to the extracellular kinase domain, whereas the mutation is in the intracellular kinase domain. *)
  shows "∃x y z e1 e2. HER2V777L x ∧ Trastuzumab y ∧ Resistance z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 z ∧ To z y ∧ Bind e2 ∧ Agent e2 y ∧ Patient e2 x ∧ ExtracellularDomain x ∧ IntracellularDomain x"
proof -
  (* From the premise, we have known information about HER2V777L, Trastuzumab, and Resistance. *)
  from asm have "HER2V777L x ∧ Trastuzumab y ∧ Resistance z" by blast
  (* We have logical relations Implies(C, E) and Implies(F, E). *)
  (* C: The HER2 V777L mutation is located in the intracellular tyrosine kinase domain. *)
  (* E: The location of the HER2 V777L mutation can lead to resistance to trastuzumab. *)
  (* F: Trastuzumab targets the extracellular domain. *)
  (* From explanation_2, we know HER2V777L x implies C. *)
  from explanation_2 have "HER2V777L x ⟶ (∃y. IntracellularTyrosineKinaseDomain y ∧ LocatedIn x y)" sledgehammer
  (* From explanation_4, we know E implies A. *)
  from explanation_4 have "HER2V777L x ⟶ (∃y z w e1 e2. IntracellularTyrosineKinaseDomain y ∧ Resistance z ∧ Trastuzumab w ∧ Location x y ∧ Lead e1 ∧ Agent e1 y ∧ Patient e1 z ∧ To z w ∧ Target e2 ∧ Agent e2 w ∧ Patient e2 y)" <ATP>
  (* From explanation_1, we know A: Trastuzumab binds specifically to the HER2 extracellular domain. *)
  from explanation_1 have "∃x y z e1 e2. Trastuzumab x ∧ HER2 y ∧ ExtracellularDomain y ∧ Bind e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Specifically e1 ∧ Mutation z ∧ IntracellularDomain z ∧ Inhibit e2 ∧ ¬Agent e2 x ∧ Patient e2 z" <ATP>
  (* Using the logical relations and derived implications, we can infer the hypothesis. *)
  then have "∃x y z e1 e2. HER2V777L x ∧ Trastuzumab y ∧ Resistance z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 z ∧ To z y ∧ Bind e2 ∧ Agent e2 y ∧ Patient e2 x ∧ ExtracellularDomain x ∧ IntracellularDomain x" <ATP>
  then show ?thesis <ATP>
qed

end
